FI894693A0 - Förfarande för framställning av farmaceutiskt värdefullt imidazolinderivat - Google Patents

Förfarande för framställning av farmaceutiskt värdefullt imidazolinderivat

Info

Publication number
FI894693A0
FI894693A0 FI894693A FI894693A FI894693A0 FI 894693 A0 FI894693 A0 FI 894693A0 FI 894693 A FI894693 A FI 894693A FI 894693 A FI894693 A FI 894693A FI 894693 A0 FI894693 A0 FI 894693A0
Authority
FI
Finland
Prior art keywords
preparation
imidazoline derivatives
pharmaceutically valuable
group
pharmaceutically
Prior art date
Application number
FI894693A
Other languages
English (en)
Finnish (fi)
Other versions
FI894693A (sv
FI94632B (sv
FI94632C (sv
Inventor
Kazuo Matsumoto
Mamoru Suzuki
Kozo Yamamoto
Isao Takata
Yoshio Iwasawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of FI894693A0 publication Critical patent/FI894693A0/sv
Publication of FI894693A publication Critical patent/FI894693A/sv
Publication of FI94632B publication Critical patent/FI94632B/sv
Application granted granted Critical
Publication of FI94632C publication Critical patent/FI94632C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI894693A 1988-10-06 1989-10-04 Förfarande för framställning av farmaceutiskt värdefullt imidazolinderivat FI94632C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63253391A JPH02101065A (ja) 1988-10-06 1988-10-06 イミダゾリン誘導体及びその製法
JP25339188 1988-10-06

Publications (4)

Publication Number Publication Date
FI894693A0 true FI894693A0 (sv) 1989-10-04
FI894693A FI894693A (sv) 1990-04-07
FI94632B FI94632B (sv) 1995-06-30
FI94632C FI94632C (sv) 1995-10-10

Family

ID=17250719

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894693A FI94632C (sv) 1988-10-06 1989-10-04 Förfarande för framställning av farmaceutiskt värdefullt imidazolinderivat

Country Status (17)

Country Link
US (1) US5051441A (sv)
EP (1) EP0363061B1 (sv)
JP (1) JPH02101065A (sv)
KR (1) KR960009570B1 (sv)
CN (1) CN1020096C (sv)
AT (1) ATE78470T1 (sv)
AU (1) AU611827B2 (sv)
CA (1) CA1330997C (sv)
DE (1) DE68902209T2 (sv)
DK (1) DK491489A (sv)
ES (1) ES2052015T3 (sv)
FI (1) FI94632C (sv)
GR (1) GR3005779T3 (sv)
HK (1) HK143095A (sv)
HU (1) HU202211B (sv)
IE (1) IE61924B1 (sv)
IL (1) IL91704A0 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92441A (en) * 1988-12-07 1993-05-13 Tanabe Seiyaku Co Imidazole containing peptides, their preparation and pharmaceutical compositions containing them
GB9020889D0 (en) * 1990-09-25 1990-11-07 May & Baker Ltd New compositions of matter
JP2564380Y2 (ja) * 1993-12-10 1998-03-09 大阪瓦斯株式会社 締付トルク確認継手
DE19540027A1 (de) * 1995-10-27 1997-04-30 Gruenenthal Gmbh Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe
KR100426204B1 (ko) * 1998-05-23 2004-06-24 문승자 합성수지판제조방법
US6365616B1 (en) 1998-08-31 2002-04-02 Sentron Medical, Inc. Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
US20020142974A1 (en) * 1998-09-11 2002-10-03 Leonard D. Kohn Immune activation by double-stranded polynucleotides
DE60227108D1 (de) 2001-12-18 2008-07-24 Hoffmann La Roche Cis-imidazoline als mdm2-hemmer
US7132421B2 (en) 2003-06-17 2006-11-07 Hoffmann-La Roche Inc. CIS-imidazoles
EP1643989B1 (en) * 2003-06-17 2010-04-28 F. Hoffmann-La Roche Ag Cis-imidazolines as mdm2 inhibitors
US7425638B2 (en) 2003-06-17 2008-09-16 Hoffmann-La Roche Inc. Cis-imidazolines
ES2314660T3 (es) 2004-05-18 2009-03-16 F. Hoffmann-La Roche Ag Nuevas cis-imidazolinas.
US7893278B2 (en) 2004-06-17 2011-02-22 Hoffman-La Roche Inc. CIS-imidazolines
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP2311814A1 (en) 2005-12-01 2011-04-20 F. Hoffmann-La Roche AG 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents
EP1979338A1 (en) 2006-01-18 2008-10-15 F.Hoffmann-La Roche Ag Cis-4, 5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors
US7625895B2 (en) 2007-04-12 2009-12-01 Hoffmann-Le Roche Inc. Diphenyl-dihydro-imidazopyridinones
JP5324586B2 (ja) 2007-10-09 2013-10-23 エフ．ホフマン−ラ ロシュ アーゲー キラルシス−イミダゾリン
US8252942B2 (en) * 2007-10-09 2012-08-28 Board Of Trustees Of Michigan State University Substituted imidazoline compounds
BR112016016674A2 (pt) * 2014-01-29 2017-08-08 Toray Industries Agente terapêutico ou profilático para uso no tratamento de esclerose múltipla

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH44279A (fr) * 1908-03-09 1909-07-16 Anonima Per Frigorigeni E Moto Appareil pour l'échange de chaleur entre des fluides sous pression
NL296772A (sv) * 1962-03-21
GB1047569A (en) * 1962-10-31 1966-11-09 Du Pont Light-sensitive compositions
US3707475A (en) * 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
EP0005219B1 (en) * 1978-04-24 1981-07-22 A/S Dumex (Dumex Ltd.) Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them
US4424229A (en) * 1979-04-23 1984-01-03 A/S Dumex (Dumex Ltd.) Fluorine containing 2,4,5-triphenylimidazoles
US4252887A (en) * 1979-08-14 1981-02-24 E. I. Du Pont De Nemours And Company Dimers derived from unsymmetrical 2,4,5-triphenylimidazole compounds as photoinitiators
DE3141063A1 (de) * 1981-10-13 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
GB8906198D0 (en) * 1989-03-17 1989-05-04 Ciba Geigy Ag Compounds

Also Published As

Publication number Publication date
HU202211B (en) 1991-02-28
ES2052015T3 (es) 1994-07-01
JPH02101065A (ja) 1990-04-12
KR960009570B1 (ko) 1996-07-20
FI894693A (sv) 1990-04-07
DK491489A (da) 1990-04-07
JPH0581592B2 (sv) 1993-11-15
FI94632B (sv) 1995-06-30
EP0363061A1 (en) 1990-04-11
DE68902209T2 (de) 1992-12-10
EP0363061B1 (en) 1992-07-22
ATE78470T1 (de) 1992-08-15
US5051441A (en) 1991-09-24
FI94632C (sv) 1995-10-10
HK143095A (en) 1995-09-15
KR900006296A (ko) 1990-05-07
HUT51601A (en) 1990-05-28
AU611827B2 (en) 1991-06-20
DE68902209D1 (de) 1992-08-27
CN1041760A (zh) 1990-05-02
GR3005779T3 (sv) 1993-06-07
DK491489D0 (da) 1989-10-05
IE892977L (en) 1990-04-06
IL91704A0 (en) 1990-06-10
AU4236889A (en) 1990-04-12
IE61924B1 (en) 1994-11-30
CA1330997C (en) 1994-07-26
CN1020096C (zh) 1993-03-17
HU895226D0 (en) 1990-01-28

Similar Documents

Publication Publication Date Title
FI894693A0 (sv) Förfarande för framställning av farmaceutiskt värdefullt imidazolinderivat
MX9306831A (es) Nuevos compuestos heterociclicos.
FI96857B (sv) Förfarande för framställning av en farmakologiskt användbar tiazolförening
NO159017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,3,4-tetrahydroisokinolin-3-karboksylsyre-derivater.
NO176356C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive pyrazolopyridinforbindelser
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
HUT61300A (en) Process for producing pyrazolepyridine derivatives and pharmaceutical compositions comprising same as active ingredient
NZ229347A (en) Substituted cephalosporin derivatives; pharmaceutical compositions, preparatory processes and intermediates
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
HUT64318A (en) Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance
DE69329184D1 (de) Alkylsubstituierte heterocyclische Verbindungen
NZ227682A (en) Thioformamide derivatives, preparation thereof and pharmaceutical compositions
NO174886C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidin-derivater
FI894125A0 (sv) Analogiförfarande för framställning av en terapeutiskt användbar 3-piperidinyl-indazol
EP0420086A3 (en) Pyrimidoindole derivatives and processes for preparation thereof

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: TANABE SEIYAKU CO., . LTD.